celecoxib has been researched along with Asthma in 16 studies
Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Eighteen subjects with asthma participated in a cross-over study where celecoxib 200mg or placebo were given b." | 9.15 | Effects of celecoxib on major prostaglandins in asthma. ( Daham, K; Dahlén, B; Dahlén, SE; FitzGerald, GA; Gülich, A; Kupczyk, M; Lawson, JA; Song, WL, 2011) |
| "A special regulatory role for prostaglandin E2 has been postulated in aspirin-induced asthma." | 9.13 | Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity. ( Cmiel, A; Gawlewicz-Mroczka, A; Gielicz, A; Mastalerz, L; Sanak, M; Szczeklik, A, 2008) |
| "To determine whether celecoxib, a selective cyclooxygenase 2 (COX-2) inhibitor, cross-reacts in patients with aspirin-exacerbated respiratory disease (AERD) with asthma." | 9.10 | The safety of celecoxib in patients with aspirin-sensitive asthma. ( Simon, RA; Stevenson, DD; Woessner, KM, 2002) |
| "Subjects with aspirin-intolerant asthma (AIA) respond with bronchoconstriction and extrapulmonary adverse reactions to conventional nonsteroidal anti-inflammatory drugs (NSAIDs) that inhibit the cyclooxygenase (COX) step in the biosynthesis of prostaglandins." | 9.10 | Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib. ( Bochenek, G; Dahlén, B; Dahlén, SE; Drupka, D; Gyllfors, P; Isakson, PC; Kumlin, M; Lefkowith, JB; Mejza, F; Murray, JJ; Nizankowska, E; Overholt, J; Sheller, J; Szczeklik, A, 2003) |
| "To review the safety of cyclooxygenase-2 (COX-2) inhibitors in asthma patients with aspirin hypersensitivity." | 8.82 | Safety of COX-2 inhibitors in asthma patients with aspirin hypersensitivity. ( Fernández, C; West, PM, 2003) |
| "The Fernand Widal syndrome is a set of associations between asthma, nasal polyposis and aspirin sensitivity." | 7.88 | [Is celecoxib a safe alternative for the Fernand Widal syndrome?] ( De Blay, F; Guenard-Bilbaut, L; Metz-Favre, C; Schaller, A, 2018) |
| "In 5-10% of adult patients with asthma, aspirin and most other nonsteroidal anti-inflammatory drugs (NSAIDs) precipitate acute asthmatic attacks." | 7.72 | Celecoxib, a highly selective COX-2 inhibitor, is safe in aspirin-induced asthma patients. ( Alfaya, T; Berges, P; Camacho, E; García-Rodriguez, R; Hinojosa, M; Martín-García, C, 2003) |
| "We describe the case of an aspirin-sensitive asthma patient with a history of anaphylactic reactions to nonsteroidal anti-inflammatory drugs." | 7.71 | Successful use of cyclooxygenase-2 inhibitor in a patient with aspirin-induced asthma. ( Fischer, R; Harrell, K; Marks, F, 2001) |
| "Eighteen subjects with asthma participated in a cross-over study where celecoxib 200mg or placebo were given b." | 5.15 | Effects of celecoxib on major prostaglandins in asthma. ( Daham, K; Dahlén, B; Dahlén, SE; FitzGerald, GA; Gülich, A; Kupczyk, M; Lawson, JA; Song, WL, 2011) |
| "A special regulatory role for prostaglandin E2 has been postulated in aspirin-induced asthma." | 5.13 | Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity. ( Cmiel, A; Gawlewicz-Mroczka, A; Gielicz, A; Mastalerz, L; Sanak, M; Szczeklik, A, 2008) |
| " Three subjects with multiple-drug induced urticaria complained of a generalized reaction after challenge (Two due to celecoxib and one due to meloxicam)." | 5.11 | Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients. ( Antonicelli, L; Bilò, MB; Bonadonna, P; Crivellaro, MA; Dama, AR; Schiappoli, M; Senna, G, 2004) |
| "To determine whether celecoxib, a selective cyclooxygenase 2 (COX-2) inhibitor, cross-reacts in patients with aspirin-exacerbated respiratory disease (AERD) with asthma." | 5.10 | The safety of celecoxib in patients with aspirin-sensitive asthma. ( Simon, RA; Stevenson, DD; Woessner, KM, 2002) |
| "Subjects with aspirin-intolerant asthma (AIA) respond with bronchoconstriction and extrapulmonary adverse reactions to conventional nonsteroidal anti-inflammatory drugs (NSAIDs) that inhibit the cyclooxygenase (COX) step in the biosynthesis of prostaglandins." | 5.10 | Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib. ( Bochenek, G; Dahlén, B; Dahlén, SE; Drupka, D; Gyllfors, P; Isakson, PC; Kumlin, M; Lefkowith, JB; Mejza, F; Murray, JJ; Nizankowska, E; Overholt, J; Sheller, J; Szczeklik, A, 2003) |
| "Nonsteroidal anti-inflammatory drugs (NSAIDs) cause bronchospasm in susceptible patients with asthma, often termed aspirin-exacerbated respiratory disease (AERD), with the risk being greatest after acute exposure." | 4.90 | Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: Meta-analysis of controlled clinical trials. ( Donnan, PT; Guthrie, B; Jackson, C; Lipworth, BJ; Morales, DR; Santiago, VH, 2014) |
| "To review the safety of cyclooxygenase-2 (COX-2) inhibitors in asthma patients with aspirin hypersensitivity." | 4.82 | Safety of COX-2 inhibitors in asthma patients with aspirin hypersensitivity. ( Fernández, C; West, PM, 2003) |
| "The Fernand Widal syndrome is a set of associations between asthma, nasal polyposis and aspirin sensitivity." | 3.88 | [Is celecoxib a safe alternative for the Fernand Widal syndrome?] ( De Blay, F; Guenard-Bilbaut, L; Metz-Favre, C; Schaller, A, 2018) |
| "In 5-10% of adult patients with asthma, aspirin and most other nonsteroidal anti-inflammatory drugs (NSAIDs) precipitate acute asthmatic attacks." | 3.72 | Celecoxib, a highly selective COX-2 inhibitor, is safe in aspirin-induced asthma patients. ( Alfaya, T; Berges, P; Camacho, E; García-Rodriguez, R; Hinojosa, M; Martín-García, C, 2003) |
| "We describe the case of an aspirin-sensitive asthma patient with a history of anaphylactic reactions to nonsteroidal anti-inflammatory drugs." | 3.71 | Successful use of cyclooxygenase-2 inhibitor in a patient with aspirin-induced asthma. ( Fischer, R; Harrell, K; Marks, F, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (75.00) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schaller, A | 1 |
| Metz-Favre, C | 1 |
| Guenard-Bilbaut, L | 1 |
| De Blay, F | 1 |
| Morales, DR | 1 |
| Lipworth, BJ | 1 |
| Guthrie, B | 1 |
| Jackson, C | 1 |
| Donnan, PT | 1 |
| Santiago, VH | 1 |
| Muñoz-Cano, R | 1 |
| Bartra, J | 1 |
| Vennera, MC | 1 |
| Valero, A | 1 |
| Picado, C | 1 |
| Daham, K | 1 |
| Song, WL | 1 |
| Lawson, JA | 1 |
| Kupczyk, M | 1 |
| Gülich, A | 1 |
| Dahlén, SE | 2 |
| FitzGerald, GA | 1 |
| Dahlén, B | 3 |
| Sanak, M | 3 |
| Woessner, KM | 1 |
| Simon, RA | 1 |
| Stevenson, DD | 1 |
| Gyllfors, P | 1 |
| Bochenek, G | 1 |
| Overholt, J | 1 |
| Drupka, D | 1 |
| Kumlin, M | 1 |
| Sheller, J | 1 |
| Nizankowska, E | 1 |
| Isakson, PC | 1 |
| Mejza, F | 1 |
| Lefkowith, JB | 1 |
| Szczeklik, A | 4 |
| Murray, JJ | 2 |
| Martín-García, C | 1 |
| Hinojosa, M | 1 |
| Berges, P | 1 |
| Camacho, E | 1 |
| García-Rodriguez, R | 1 |
| Alfaya, T | 1 |
| West, PM | 1 |
| Fernández, C | 1 |
| Senna, G | 1 |
| Bilò, MB | 1 |
| Antonicelli, L | 1 |
| Schiappoli, M | 1 |
| Crivellaro, MA | 1 |
| Bonadonna, P | 1 |
| Dama, AR | 1 |
| Baldassarre, S | 1 |
| Schandene, L | 1 |
| Choufani, G | 1 |
| Michils, A | 1 |
| Mastalerz, L | 2 |
| Gawlewicz, A | 1 |
| Gielicz, A | 2 |
| Faber, J | 1 |
| Gawlewicz-Mroczka, A | 1 |
| Cmiel, A | 1 |
| Marks, F | 1 |
| Harrell, K | 1 |
| Fischer, R | 1 |
| Dicpinigaitis, PV | 1 |
2 reviews available for celecoxib and Asthma
| Article | Year |
|---|---|
Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: Meta-analysis of controlled clinical trials.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Bronchial Spasm; Celecoxib; Clinical Trial | 2014 |
Safety of COX-2 inhibitors in asthma patients with aspirin hypersensitivity.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Celecoxib; Cyclooxygenase 2; Drug Hypersen | 2003 |
6 trials available for celecoxib and Asthma
| Article | Year |
|---|---|
Effects of celecoxib on major prostaglandins in asthma.
Topics: Adolescent; Adult; Aged; Asthma; Celecoxib; Cross-Over Studies; Drug Administration Schedule; Female | 2011 |
The safety of celecoxib in patients with aspirin-sensitive asthma.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Celecoxib; Cyclooxygenase Inhibitors; Dose | 2002 |
Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Celecoxib; Cross-Over Studies | 2003 |
Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients.
Topics: Adolescent; Adult; Aged; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Celec | 2004 |
Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity.
Topics: Adult; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Case-Control | 2008 |
Effect of the cyclooxygenase-2 inhibitor celecoxib on bronchial responsiveness and cough reflex sensitivity in asthmatics.
Topics: Adult; Airway Resistance; Asthma; Bronchi; Celecoxib; Cough; Cross-Over Studies; Cyclooxygenase 2; C | 2001 |
8 other studies available for celecoxib and Asthma
| Article | Year |
|---|---|
[Is celecoxib a safe alternative for the Fernand Widal syndrome?]
Topics: Adult; Aged; Aspirin; Asthma; Case-Control Studies; Celecoxib; Drug Hypersensitivity; Female; France | 2018 |
Asthmatic reaction induced by celecoxib in a patient with aspirin-induced asthma.
Topics: Adult; Aspirin; Asthma; Bronchial Spasm; Celecoxib; Cyclooxygenase Inhibitors; Drug Hypersensitivity | 2009 |
Coxibs strike back.
Topics: Asthma; Celecoxib; Female; Humans; Male; Prostaglandins; Pyrazoles; Sulfonamides | 2011 |
Celecoxib, a highly selective COX-2 inhibitor, is safe in aspirin-induced asthma patients.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Celecoxib; Cyclooxygenase 2; | 2003 |
Asthma attacks induced by low doses of celecoxib, aspirin, and acetaminophen.
Topics: Acetaminophen; Aspirin; Asthma; Celecoxib; Cyclooxygenase Inhibitors; Female; Humans; Leukotriene E4 | 2006 |
Different eicosanoid profile of the hypersensitivity reactions triggered by aspirin and celecoxib in a patient with sinusitis, asthma, and urticaria.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Celecoxib; Drug Hypersensitivity; E | 2006 |
Celecoxib in patients with asthma and aspirin intolerance. The Celecoxib in Aspirin-Intolerant Asthma Study Group.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Asthma; Bronchial Spasm; Celecoxib; Cyclooxygenase 2; Cyclo | 2001 |
Successful use of cyclooxygenase-2 inhibitor in a patient with aspirin-induced asthma.
Topics: Aged; Anaphylaxis; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Aspirin; Asthma; | 2001 |